• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. Management of oral Submucous Fibrosis with oral lycopene and injection Kenacort, Hyaluronidase intradermally

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

Management of oral Submucous Fibrosis with oral lycopene and injection Kenacort, Hyaluronidase intradermally

    Author

    • Dr Apurab Gupta, Dr Rajesh Sharma, Dr Gopika Kalsotra, Dr Parmod Kalsotra
,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

Background: Oral submucous fibrosis (OSMF) is an oral precancerous condition characterized by inflammation and progressive fibrosis of the submucosal tissues resulting in marked rigidity and trismus. OSMF is still challenging for clinicians due to elusive pathogenesis and less well-defined classification systems.However current treatment strategy with oral lycopene andintralesional injection of  kennacort and hyaluronidase  is effective to some extent .
Methods: A total of 30 patients diagnosed with OSMF were treated in SMGS hospital, GMC jammu for a span of 9 months. They were treated with oral lycopene and intralesional injection of kennacort and hyaluronidase weekly for 6 weeks.
Results: There was significant improvement in opening of mouth and definite reduction in burning sensation, painful ulceration and blanching of buccal mucosa.
Conclusion: Management of OSMF includes counseling of patients along with oral lycopene with intradermal injection of kennacort with hyaluronidase, is highly effacious and cost effective in improving the mouth opening and recing other symptoms in patients with OSMF, whereas advanced stages should be treated surgically.

  • XML
  • PDF 300.72 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 21
    • PDF Download: 92
European Journal of Molecular & Clinical Medicine
Volume 9, Issue 7
September 2022
Page 3399-3404
Files
  • XML
  • PDF 300.72 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 21
  • PDF Download: 92

APA

Dr Parmod Kalsotra, D. A. G. D. R. S. D. G. K. (2022). Management of oral Submucous Fibrosis with oral lycopene and injection Kenacort, Hyaluronidase intradermally. European Journal of Molecular & Clinical Medicine, 9(7), 3399-3404.

MLA

Dr Apurab Gupta, Dr Rajesh Sharma, Dr Gopika Kalsotra, Dr Parmod Kalsotra. "Management of oral Submucous Fibrosis with oral lycopene and injection Kenacort, Hyaluronidase intradermally". European Journal of Molecular & Clinical Medicine, 9, 7, 2022, 3399-3404.

HARVARD

Dr Parmod Kalsotra, D. A. G. D. R. S. D. G. K. (2022). 'Management of oral Submucous Fibrosis with oral lycopene and injection Kenacort, Hyaluronidase intradermally', European Journal of Molecular & Clinical Medicine, 9(7), pp. 3399-3404.

VANCOUVER

Dr Parmod Kalsotra, D. A. G. D. R. S. D. G. K. Management of oral Submucous Fibrosis with oral lycopene and injection Kenacort, Hyaluronidase intradermally. European Journal of Molecular & Clinical Medicine, 2022; 9(7): 3399-3404.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus